|
Literature for DOID 0111349: hereditary desmoid disease
Xenbase Articles

(

CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.,
Naert T,Tulkens D,Van Nieuwenhuysen T,Przybyl J,Demuynck S,van de Rijn M,Al-Jazrawe M,Alman BA,Coucke PJ,De Leeneer K,Vanhove C,Savvides SN,Creytens D,Vleminckx K,Vleminckx K,
Proc Natl Acad Sci U S A. November 23, 2021; 118(47):1091-6490.
![]() |